This is the authors' abstract. We don't add key points for this paper.
Small change, big difference: The introduction of an additional CH2 group into the bridge of ligands with two P/N units leads to a different selectivity of the corresponding chromium-based catalysts. Whereas 1 produces an ethylene trimerization system, 2 provides an unprecedented ethylene tetramerization system that produces 1-octene with high purity and little or no polymer side products (see scheme; DMAO=Me3Al-depleted methylaluminoxane).
No takes yet. Share an insight, caveat, or question.
Shaikh et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: